Anush Shares and Securities

CLOSE X
Equity 
YOU ARE ON : Home | Equity | Comapny Profile | Summary
Summary
Sun Pharmaceutical Industries Ltd.
BSE CODE: 524715   |   ISIN CODE : INE044A01036
BSE
516.45
-0.6 ( -0.12% )
 
Prev Close ( Rs.)
517.05
Open ( Rs.)
517.05
 
High ( Rs.)
521.85
Low ( Rs.)
514.50
 
Volume
199557
Week Avg.Volume
524212
 
52 WK High-Low Range
BSE NSE
517.15
0.05 ( 0.01% )
 
Prev Close ( Rs.)
517.10
Open ( Rs.)
520.00
 
High ( Rs.)
521.85
Low ( Rs.)
514.30
 
Volume
1977341
Week Avg.Volume
5137672
 
52 WK High-Low Range
432.7
730.95
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
You need to upgrade your Flash Player
Competitors
Company NameLast Price (Rs.)Chg (Rs./%)Sales TurnOverVolume
Zandu Realty1498.65158.55(11.83)2328.967085.00
Ajanta Pharma1336.2064.50(5.07)170.8974151.00
Eris Lifesciences624.3039.20(6.70)39.8589524.00
Pfizer1964.3536.15(1.87)528.745910.00
Abbott India4974.8032.80(0.66)652.703225.00
More>
KEY PERSONNEL & ADDRESS
Chairman
Israel Makov
Managing Director
Dilip S Shanghvi
Company Secretary
Sunil R Ajmera
Non Executive Independent Director
Mohanchand Dadha
Keki M Mistry
Registered Office :
Sun Pharma Advanced Research Centre (S P A R C),Tandalja,, Vadodara,
Gujarat-390020 .
Phone :
0265- 5515500 / 5515600 / 5515700  
E-mail :
secretarial@sunpharma.com
URL
www.sunpharma.com
 
News On SUNPHARMA
16/11/2017
Sun Pharmaceutical advances on...
15/11/2017
Sun Pharma gets nod for scheme...
26/10/2017
Sun Pharma’s arm receives USFD...
26/10/2017
Sun Pharma rises with arm rece...
More >
Financials
QUARTERLY (Sep 17)
Net Profit( Rs . In Cr) 5770.5
Gross Profit( Rs . In Cr) 5736.3
Operating Profit( Rs . In Cr) 8082.9
Net Sales( Rs .In Cr) 18238.4
More>
MF Holding Details
Scheme NameMkt value (In Cr.)
ICICI Pru Value Disc...1651.57
SBI-ETF Nifty 50354.44
ICICI Pru Focused Bl...322.56
ICICI Pru Balanced F...256.66
Kotak Equity Arbitra...209.63
ICICI Pru Balanced A...192.27
HDFC Arbitrage-WP(G)180.49
More>
Attention Investors: "Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors. "
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account
Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Exchange / CDSL on the same day.........issued in the interest of investors.
SEBI REGN NO: NSE~ INB/F/E 231445330 | BSE~INB/F 231445330 | MSE- INB040817131 | DP~IN-DP-CDSL-683-2013 | Member ID : NSE :14453 | BSE: 6281 |MSE: 08171| MCX-SX: 11280 |SCM F&O: M50171 | AMFI: 2110

NSE
×